Cargando…
The enzymes. isoprenoids, polyphenols and flavonoids / Volume thirty-six, Natural products and cancer signaling :
Natural compounds from a variety of natural resources including plants have emerged as important source of anticancer drug development. This special issue will highlight the significant advance in elucidating mechanisms of action of these natural compounds, focusing especially on isoprenoids and pol...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam :
Elsevier,
2014.
|
| Colección: | Enzymes ;
volume 36. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn898102459 | ||
| 003 | OCoLC | ||
| 005 | 20231120111926.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 141213s2014 ne ob 001 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d N$T |d OPELS |d YDXCP |d UIU |d OCLCF |d IDEBK |d DEBSZ |d OCLCQ |d DEBBG |d CUY |d ZCU |d USU |d MERUC |d OCLCO |d ICG |d OCLCO |d DKC |d S4S |d LOA |d K6U |d COCUF |d VT2 |d CNCGM |d D6H |d AU@ |d OCLCQ |d OCLCO |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 899564967 |a 913622116 |a 928735616 |a 956678128 |a 987778697 | ||
| 020 | |a 9780128025277 |q (electronic bk.) | ||
| 020 | |a 0128025271 |q (electronic bk.) | ||
| 020 | |z 0128022159 | ||
| 020 | |z 9780128022153 | ||
| 035 | |a (OCoLC)898102459 |z (OCoLC)899564967 |z (OCoLC)913622116 |z (OCoLC)928735616 |z (OCoLC)956678128 |z (OCoLC)987778697 | ||
| 050 | 4 | |a RC271.A62 | |
| 060 | 4 | |a QU 135 |b B791e v.36 2014 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.99406 |2 23 |
| 245 | 0 | 4 | |a The enzymes. |n Volume thirty-six, |p Natural products and cancer signaling : |b isoprenoids, polyphenols and flavonoids / |c edited by S. Zahra Bathaie, Fuyuhiko Tamanoi. |
| 260 | |a Amsterdam : |b Elsevier, |c 2014. | ||
| 300 | |a 1 online resource (279 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Enzymes ; |v volume 36 | |
| 520 | |a Natural compounds from a variety of natural resources including plants have emerged as important source of anticancer drug development. This special issue will highlight the significant advance in elucidating mechanisms of action of these natural compounds, focusing especially on isoprenoids and polyphenols/flavonoids. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Front Cover -- The Enzymes: Natural Products and Cancer Signaling: Isoprenoids, Polyphenols and Flavonoids -- Copyright -- Contents -- Contributors -- Preface -- Chapter One: Introduction -- References -- Chapter Two: Perillyl Alcohol (Monoterpene Alcohol), Limonene -- 1. Introduction -- 2. Perillyl Alcohol -- 2.1. Perillyl Alcohol Mechanism of Action in Cancer Therapy and Pharmacokinetics -- 2.2. Perillyl Alcohol Biosafety and Adverse Effects in Clinical Application and Clinical Trials -- 3. Limonene -- 3.1. Limonene Pharmacokinetics -- 3.2. Limonene Anticancer Activity and Clinical Trials. | |
| 505 | 8 | |a 3.3. Limonene Mechanisms of Action, Targets, and Clinical Applications -- 3.4. Limonene Biosafety and Adverse Effects -- 4. Concluding Remarks -- Acknowledgment -- References -- Chapter Three: Ganoderic Acid and Lucidenic Acid (Triterpenoid) -- 1. Introduction -- 2. Lucidenic Acids and Ganoderic Acids from Ganoderma Species -- 2.1. The Sources of Lucidenic Acids and Ganoderic Acids -- 2.2. The Biosynthesis of Ganoderic Acids -- 2.3. Optimization of the Fermentation Process -- 3. Biological Functions of Lucidenic Acids and Ganoderic Acids -- 3.1. Cytotoxic and Apoptotic Effects. | |
| 505 | 8 | |a 3.2. Cell Cycle Arrest -- 3.3. Anti-invasive Effect -- 3.4. Autophagy -- 3.5. Anti-inflammatory Effect -- 3.6. Antiosteoclastogenesis -- 3.7. Antiasthma -- 3.8. Antihepatitis B Activity -- 4. Pharmacokinetics of Ganoderic Acids -- 5. Conclusion -- References -- Chapter Four: Anticancer Effect and Molecular Targets of Saffron Carotenoids -- 1. Introduction -- 2. Anticancer Effect of Saffron and Its Carotenoids -- 3. Comparing the Efficacy of Crocetin, Crocin, and Other Components -- 4. Liposome Formulation of Saffron Compounds. | |
| 505 | 8 | |a 5. Effect of Crocetin and Crocin on Macromolecule Synthesis and Structure -- 5.1. Effect on DNA, RNA, and Protein Synthesis -- 5.2. Protein Binding -- 6. Effects on Cell Cycle, Apoptosis, and Signaling Pathways -- 7. Role of Saffron Components on Chemoprevention -- 8. Molecular Mechanisms Involved in the Protective Effect of Saffron Components against Various Damages in Different Tissues -- 9. Antioxidant and Anti-inflammatory Effects of Saffron -- 10. Safety -- 11. Other Mechanisms -- 12. Conclusions -- References -- Chapter Five: Zerumbone from Ginger (Monoterpenoid) -- 1. Introduction. | |
| 505 | 8 | |a 2. Characteristic Feature -- 3. Target Pathways by Zerumbone -- 3.1. Survival -- 3.1.1. Caspase Family -- 3.1.2. Bcl Family -- 3.1.3. c-FLIP -- 3.1.4. G2/M Cell Cycle -- 3.2. Proliferation -- 3.2.1. Cyclin B1/CDK1 -- 3.2.2. Tumor Necrosis Factor -- 3.3. Invasion -- 3.4. Angiogenesis -- 4. Nuclear Factor-Kappa B -- 5. Future Perspectives -- References -- Chapter Six: Research Progress on Natural Triterpenoid Saponins in the Chemoprevention and Chemotherapy of Cancer -- 1. Introduction -- 2. Triterpenoid Saponins in the Prevention and Therapy of Cancers. | |
| 650 | 0 | |a Cancer |x Alternative treatment. | |
| 650 | 0 | |a Cancer |x Treatment. | |
| 650 | 0 | |a Enzymes. | |
| 650 | 0 | |a Antimitotic agents. | |
| 650 | 0 | |a Antineoplastic agents. | |
| 650 | 2 | |a Enzymes |0 (DNLM)D004798 | |
| 650 | 2 | |a Biological Products |x pharmacology |0 (DNLM)D001688Q000494 | |
| 650 | 2 | |a Terpenes |x pharmacology |0 (DNLM)D013729Q000494 | |
| 650 | 2 | |a Polyphenols |x pharmacology |0 (DNLM)D059808Q000494 | |
| 650 | 2 | |a Flavonoids |x pharmacology |0 (DNLM)D005419Q000494 | |
| 650 | 2 | |a Antineoplastic Agents |0 (DNLM)D000970 | |
| 650 | 2 | |a Antimitotic Agents |0 (DNLM)D050256 | |
| 650 | 6 | |a Cancer |x M�edecines parall�eles. |0 (CaQQLa)201-0209748 | |
| 650 | 6 | |a Cancer |x Traitement. |0 (CaQQLa)201-0004693 | |
| 650 | 6 | |a Enzymes. |0 (CaQQLa)201-0002557 | |
| 650 | 6 | |a Anticanc�ereux. |0 (CaQQLa)201-0004692 | |
| 650 | 7 | |a enzyme. |2 aat |0 (CStmoGRI)aat300212647 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Enzymes |2 fast |0 (OCoLC)fst00913605 | |
| 650 | 7 | |a Antineoplastic agents |2 fast |0 (OCoLC)fst00810595 | |
| 650 | 7 | |a Antimitotic agents |2 fast |0 (OCoLC)fst00810570 | |
| 650 | 7 | |a Cancer |x Alternative treatment |2 fast |0 (OCoLC)fst00845320 | |
| 650 | 7 | |a Cancer |x Treatment |2 fast |0 (OCoLC)fst00845538 | |
| 700 | 1 | |a Bathaie, S. Zahra, |e editor. | |
| 700 | 1 | |a Tamanoi, Fuyuhiko, |e editor. | |
| 776 | 0 | 8 | |i Print version: |a Tamanoi, Fuyuhiko. |t Natural Products and Cancer Signaling: Isoprenoids, Polyphenols and Flavonoids. |d Burlington : Elsevier Science, �2014 |z 9780128022153 |
| 830 | 0 | |a Enzymes ; |v volume 36. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128022153 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/18746047/36 |z Texto completo |